Literature DB >> 10560126

Sarcoidosis in the western region of Saudi Arabia.

Y Samman1, M Ibrahim, S Wali.   

Abstract

BACKGROUND AND AIM OF THE WORK: To review a general hospital's experience with sarcoidosis and the clinical pattern of the disease among the Saudis.
METHODS: Retrospective file review was carried out of all patients with proven diagnosis of sarcoidosis in a general hospital in Western Saudi Arabia over a period of 11 years (1985-1996).
RESULTS: Twenty-one patients, of whom 17 were native Saudis, had been diagnosed to have sarcoidosis during the study period. There were 5 males and 16 females. The mean age was 45 years with a range of 20-69 years. The commonest presentations were cough (43%), dyspnoea (43%), joint pain (38%), hepatomegaly (29%), splenomegaly (24%) and lymphadenopathy (24%). The biochemical analysis showed raised alkaline phosphatase in 66%, calcium level was elevated in 5% and urinary calcium was elevated in 3 out of 7 patients tested. Angiotensin Converting Enzyme was elevated in 11 of 15 patients. Tuberculin test was negative in all those tested (17 patients). The patients were classified using the Siltzbach staging into 0-3. Stage 0 (14%), Stage 1 (33%), Stage 2 (43%) and Stage 3 (10%). The gallium scan was positive in 90% of those who were tested (7 patients). The diagnosis in all except one patient was proven histologically. The outcome was favourable in most patients (76%), though 52% received active treatment.
CONCLUSIONS: Sarcoidosis does occur in native Saudis. On comparison with Western patterns of the disease, there is a female predominance and relative lack of cardiac, eye, parotid and central nervous system involvement. The rarity of cardiac and central nervous system involvement was comparable with other Middle Eastern studies. Sarcoidosis, though rare in our community, should still be considered in the differential diagnosis of patients with the typical presentation after excluding tuberculosis which is epidemic.

Entities:  

Mesh:

Year:  1999        PMID: 10560126

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  8 in total

1.  Leucopenia as presentation of sarcoidosis.

Authors:  Lawrence Akinsanya; Iftikhar Hussain; David Awoniyi; Khalid Usman
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

2.  Sarcoidosis in Jordan: A Study of the Clinical Phenotype and Disease Outcome.

Authors:  Fatima Alnaimat; Khaled Al Oweidat; Anas Alrwashdeh; Ahmad Alnashrati; Saba Barham; Mohammad Hijaz; Dina Murad; Sameeha Alshelleh; Nathir Obeidat
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

3.  The six-minute walk test in patients with pulmonary sarcoidosis.

Authors:  Esam H Alhamad
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

4.  Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients.

Authors:  Esam H Alhamad; Majdy M Idrees; Mohammed O Alanezi; Ahmad A Alboukai; Shaffi Ahmad Shaik
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

5.  Sarcoidosis in the eastern region of Saudi Arabia.

Authors:  Thamer H Al-Khouzaie; Jaffar A Al-Tawfiq; Faisal M Al Subhi
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

6.  Isolated Cardiac Sarcoidosis Presenting as Torsades de Pointes in a Patient With Non-ischemic Cardiomyopathy: A Case Report.

Authors:  Moustafa S Alhamadh; Thamer S Alhowaish; Abdulrahman Yousef Alhabeeb; Rakan B Alanazi; Ayah Boudal; Khalid Al Khathlan; Abdulrahman Alrashid
Journal:  Cureus       Date:  2022-09-12

7.  Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis.

Authors:  Esam H Alhamad; Mohammed O Alanezi; Majdy M Idrees; Mohammad K Chaudhry; Ali M AlShahrani; Arthur Isnani; Shaffi Shaikh
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

8.  Sarcoidosis and HIV infection in a native Saudi man.

Authors:  Islam A Ibrahim; Osama M Estaitieh; Hadeel A Alrabee; Mazen Alzahrani
Journal:  BMJ Case Rep       Date:  2018-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.